Basem Goueli MD/PhD/MBA

CancerClarity

We are in our early stages in the development of CancerClarity, which is in the clinical trial, pharmaceutical consulting, cancer center consulting, and clinical treatment forums.  We are presently in stealth mode.

CEO and Founder

CancerLight

We are in the early stages of developing CancerLight, a company in the patient education space.  We are presently in stealth mode.

Catholic Health

Medical director of hematology/medical oncology for Catholic Health System.

Medical Director of Hematology/Medical Oncology

Great Lakes Cancer Care

Director of Hematology and Medical Oncology

University at Buffalo

Associate Chief of Hematology/Medical Oncology

Covenant Health/Thompson Oncology Group

St. Luke's Reginoal Cancer Center

Director

I have directed three independent cancer institutes, collectively representing 17 hospitals and 12 cancer centers.  I am a hematologist and medical oncologist who has been the institutional principal investigator on nearly 100 clinical trials involving breast cancer, myeloma, prostate cancer, lung cancer, melanoma, ovarian cancer, head and neck cancer, myelodysplastic syndrome, CLL, DLBCL, esophageal cancer, etc.  I was on three papers published in The New England Journal of Medicine (prostate cancer, chronic neutrophilic leukemia, lung cancer) and two in Lancet (Shingles vaccine and head and neck cancer).  I am board certified in hematology, medical oncology, internal medicine, and artificial intelligence in medicine.


As depicted in my profile, my training background includes:
MD:  Mayo Clinic
PhD in biochemistry:  Mayo Clinic
MBA:  University of North Carolina, Chapel Hill
Internal Medicine Residency:  George Washington University Hospital with 4 months at the NIH
Hematology/Oncology Clinical Fellowship:  Stanford
Biochemistry Post-Doctoral Fellowship:  Stanford
MIT Xpro Course Certificate:  Designing Artificial Intelligence Products 
MIT Xpro: Course Certificate:  Robotics Essentials 
MIT Xpro: Course Certificate:  Drug and Medical Device Development 
MIT Professional Education Course Certificate:  Applied Data Science Bootcamp

I resisted the trend towards subspecialization in my career as I feel ideation often happens at the level of the forest, not the trees.  Many of the greatest future innovations will be at the interface of various disciplines. 

My area of clinical expertise is precision medicine, and my ability to treat patients in all hematology/medical oncology disciplines uniquely positions me to sequence molecular-based therapies in the context of conventional therapy and clinical trials.

I am the CEO and Founder of three companies:  CancerClarity, CancerLight, and Revolution Cancer Medical Care PLLC.  We are early in our development as we hope to disrupt the clinical trial, patient education, and clinical care forums.  Aside from building my two companies, I am a consulting medical director for 2 phase 1 Xbiotech clinical trials (pancreatic cancer), consult for numerous other pharmaceutical companies, and see patients full-time in the clinic as a hematologist/medical oncologist.  I recently turned down several high-visibility positions to pursue my vision.

My singular focus is to help as many people as I can in the shortest time frame possible.

Breast Cancer Cure

Chairperson

Breast Cancer Aotearoa Coalition

Committee Member

Breast Cancer Trials

Communications and Fundraising Sub Committee Member

New Zealand Health Research Council, Assessment Committee

Member

Standards Council of New Zealand

SNZ is New Zealand’s representative for ISO and IEC.  The organization brings together independent experts (2,000) and is largely self-funding.  The 3,000 local Standards and over 50,000 global standards underpin interoperability, minimize risk and support good practices for social, economic (1 percent of GDP), safety and environmental benefits.

Council Member

SowerbyConsulting Limited

Greater Auckland Netball Limited

Independent Director

BearingPoint

KPMG New Zealand

An experienced Trustee and Non Executive Director.  Fay gained her first Crown Entity appointment in May 2009. She provides sound judgement and adds value on boards through a strategic focus, stakeholder relationships, and a depth of experience including Audit & Risk, Strategy, ICT steering committee roles and organisational transitions following regulatory change. Earlier in her career as an internationally experienced business and change strategist with over 20 years experience in Australasia and North America across a number of industries Fay held leadership roles globally and locally, effectively evaluating and guiding changes to drive improvements in organisational performance.  She has coached and mentored Boards and senior executives in the development of a clear vision, facilitating alignment and execution to short and long term plans while effectively managing stakeholder expectations and risk. Fay brings a focus and dedication at Board level and values the collective knowledge and judgement of a board.

Specialties: Governance, Business and Change Strategist, Research Funding

Fay Sowerby

taplio

The Battle

Basem Goueli MD/PhD/MBA

Fay Sowerby

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?